MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Profit Margin (Quarterly): -47.99% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -47.99% |
| June 30, 2024 | -52.02% |
| March 31, 2024 | -42.91% |
| December 31, 2023 | -55.26% |
| September 30, 2023 | -51.91% |
| June 30, 2023 | -63.46% |
| March 31, 2023 | -79.65% |
| Date | Value |
|---|---|
| December 31, 2022 | -96.49% |
| September 30, 2022 | -121.1% |
| June 30, 2022 | -142.5% |
| March 31, 2022 | -135.4% |
| December 31, 2021 | -134.4% |
| September 30, 2021 | -138.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-142.5%
Minimum
Jun 2022
-42.91%
Maximum
Mar 2024
-89.36%
Average
-79.65%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Galapagos NV | -84.26% |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | -1.35K% |
| Celyad Oncology SA | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -650.1% |
| Return on Assets | -31.08% |
| Return on Invested Capital | -85.88% |
| Gross Profit Margin (Quarterly) | 61.22% |
| Operating Margin (Quarterly) | -26.13% |
| Return on Net Operating Assets | -40.03% |